Dr. Mikhail Artamonov, MD, MD

Write a Review570-872-9800

CLOSED NOW - Opens at 9:00am

Dr. Mikhail Artamonov, referred affectionately and syllable-saving as “Dr A” has a complex and woven background but is guided by one simple credo: the practice of Good Medicine. He believes that new medical technologies not only make medicine more effective but can actually make it more personal. He is the visionary and inspiration behind MJA HealthCare Network. Born in Moscow, Russia, his earliest experience was as an Ob-Gyn Nursing Aide… at the age of 14. Dr A then earned his medical degree at the prestigious 1st Moscow Medical Sechenov School, which consistently rates among the top medical schools in Europe. This was just the start of his training as he then earned a Master’s in Oriental Philosophy and Linguistics at Tianjin University, China; training in Psychiatry at Hannover Medical University, Germany; returned to Moscow for a PhD in Clinical Research in Prolotherapy; moved to the USA for an internship at Brooklyn Jewish Hospital; Residency Training at Temple University, Philadelphia; received a Combined Pain Fellowship at Harvard Medical School (one open position annually). As a continuation of his lifelong passion about good medicine, he graduated from the only Fellowship Program in USA in Functional, Regenerative and Anti-Aging Medicine with Board certification in this unique and highly demanded specialty with special interest in stem cell research. He was one of the founding members of American Academy of Ozonotherapy and among first 3 physicians in the US certified in both general ozone application (FAAO) and prolozone (APT) – http://aaot.us. Over 25 years of his non-stop search around our planet for the best medical knowledge he became trained in different specialties including Neurology and Physiatry, Anesthesiology and Psychiatry, Internal and Integrative Medicine. He brought together unique technologies from all over world to achieve the best for his patients. Dr. A is Board Certified in 6 major areas of Medicine.